" class="no-js "lang="en-US"> Ono Pharmaceutical - Medtech Alert
Sunday, August 03, 2025
Ono Pharmaceutical | Pharmtech Focus

Ono Pharmaceutical

About Ono Pharmaceutical

Ono Pharmaceutical

Related Story

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

May 16 2023

Personalis, the National Cancer Center, and Ono Pharmaceutical today announced they have entered into a […]

Ono Pharmaceutical to Acquire Multiple Research-Stage Oncology Programs Identified with KSQ’s CRISPRomics

January 25 2023

KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases using […]

Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases

January 17 2022

Neurimmune AG today announced that it has signed an expanded drug discovery collaboration agreement with […]

Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd.

August 6 2021

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced […]